Format

Send to

Choose Destination
Indian J Med Microbiol. 2019 Jul-Sep;37(3):351-357. doi: 10.4103/ijmm.IJMM_19_327.

Seroprevalence of Toxoplasmosis at a Tertiary Care Centre in North India from 2004 to 2014.

Author information

1
Department of Medical Parasitology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Abstract

Purpose:

This study was carried out to determine the seroprevalence of anti-Toxoplasma gondii antibodies in different groups of patients at a tertiary care hospital in North India.

Materials and Methods:

Clinical and demographic data such as age and gender of patients who had undergone testing for the presence of anti-T. gondii IgG and IgM antibodies between January 2004 and October 2014 were retrospectively analysed.

Results:

Amongst the 8397 serum samples, an overall seropositivity of 21% (n = 1763) and IgG and IgM seropositivity of 5.7% (n = 481) and 15.3% (n = 1282) were respectively observed. Compared to the period of 2004-2012 (median seroprevalence: 23.6%), a decline in seropositivity to 9.7% in 2013 and 8.1% in 2014 was noted. A rising seroprevalence with age and a higher seroprevalence in females versus males (29.5%, n = 1179 vs. 13.3%, n = 584) were recorded. The highest seroprevalence was observed in suspected ocular toxoplasmosis (47.2%, n = 47), followed by neurological (26.8%, n = 77), human immunodeficiency virus/acquired immunodeficiency syndrome (18.9%, n = 267), post-transplant (17.1%, n = 12) and congenital (7.2%, n = 144) toxoplasmosis. In patients screened for Toxoplasma exposure, the seropositivity was 47.8% (n = 11) in transplant screening and 44.9% (n = 781) in antenatal screening.

Conclusion:

Toxoplasma infection is highly prevalent in the population of North India across various clinical categories of patients. Future studies focusing on continuous monitoring of seroprevalence trends and elucidation of the risk factors associated with seropositivity in more defined groups of patients are needed.

KEYWORDS:

Antenatal screening; India; Toxoplasma gondii; human immunodeficiency virus/acquired immunodeficiency syndrome; seroprevalence

PMID:
32003332
DOI:
10.4103/ijmm.IJMM_19_327
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center